BASF Pitches 2028 Soy Launch as Jefferies Flags a Profit Gap
Published on 11/16/2026 at 21:01 | Editorial boerse-global.deBASF is rolling out global marketing for its Nemasphere soybean technology, a programme whose first commercial launches in the United States and Brazil are not due until 2028. The company puts peak sales potential at more than EUR 300 million — a figure that describes a possible future scale rather than revenue already booked or a profit forecast.
That timeline sits awkwardly beside the nearer-term picture. Jefferies downgraded the stock from "Hold" to "Underperform" on Wednesday, keeping its price target at 44 euros, and analyst Priyanka Patel pointed to thinning margins, persistent overcapacity, higher gas prices and a demand recovery that has yet to materialise. The broker also rates a possible takeover of Evonik as not attractive enough overall.
The shares slipped 0.6% on the day.
A five-percent gap on 2027
Where the two storylines meet is 2027. Jefferies sees operating earnings for that year running 5% below consensus, a spread that captures how differently the market and the broker size up BASF's future earning power. The cautious call does not contradict the Nemasphere announcement so much as address a different horizon: long-term growth on one side, the durability of near-term results on the other.
Should investors sell immediately? Or is it worth buying BASF?
For investors the question is not simply growth versus stagnation. It is whether the long-term projects justify confidence while the existing chemicals business grapples with margin pressure. The announced Capital Markets Day on 23 November now stands as the next fixed date on the calendar for that debate.
Capacity arrives before the payoff
BASF has already moved on the industrial side. On Wednesday it formally commissioned its new MDI production plant at the Geismar integrated site in Louisiana, a project costing around USD 1 billion that lifts annual MDI capacity there to roughly 600,000 tonnes — close to double the previous figure. Start-up is a completed step; the economic effect is a separate matter. The bull case requires BASF to run those additional volumes at workable margins.
Alongside that, the company agreed on Thursday to sell its global mining business to SNF. The unit employs around 140 people and includes the Cork production site. Completion is expected in 2027, subject to regulatory approvals and other customary conditions.
Shareholder returns continue in parallel. In an interim report published today, BASF disclosed the purchase of 591,344 of its own shares during the past trading week, taking total buybacks since the programme began to around 8.54 million shares. Repurchases complement the operational measures but do not substitute for an improvement in profitability.
The risk is a timing gap, not a shortage of projects
The serious counterargument rests on the market conditions Jefferies identified. If overcapacity and weak demand persist, extra production capacity could prove less valuable in economic terms than its engineering suggests, with higher gas prices squeezing the room for manoeuvre further. Nemasphere offers no immediate escape either: its launches fall after the period in which Jefferies expects below-consensus earnings, so peak sales potential should not be treated as an offset to weak chemicals margins.
BASF at a turning point? This analysis reveals what investors need to know now.
What emerges is less a lack of initiatives than a gap in time. Capital has been spent and products are being prepared, while the earnings improvement has still to arrive. Should it fail to, long-term opportunities may only partly outweigh near-term burdens in the valuation.
What the Capital Markets Day must deliver
So long as the launch schedule and the ramp-up of expanded capacity stay on track, the positive scenario keeps its footing, and a friendlier margin trend would reinforce it. If overcapacity and soft demand become entrenched, the cautious earnings view gains weight instead.
The 23 November event is the next concrete catalyst. Investors would be wise to judge any commentary by whether it makes the link between growth projects, capital deployed and future earning power easier to follow. A larger revenue opportunity alone will not be enough; a more convincing route to profitable business is what counts.
Ad
BASF Stock: New Analysis - 16 November
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
